NYSE$NHI

National Health Investors Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

Announced second quarter results, negatively impacted by higher levels of deferrals which increased from the previous quarter. Considerable progress was made on transforming NHI into a stronger healthcare REIT including significant asset sales.

National Health Investors, Inc. reported a net income of $39.183 million, or $0.85 per diluted share, for the quarter ended June 30, 2021. The results were negatively impacted by higher levels of deferrals. The company has made progress on transforming NHI into a stronger healthcare REIT.

  • Net income attributable to common stockholders per diluted common share decreased 14.1% from the same period in the prior year.
  • Normalized FAD decreased 13.3% from the same period in the prior year.
  • Normalized FFO per diluted common share decreased 20.5% from the same period in the prior year.
  • NAREIT FFO per diluted common share decreased 20.5% from the same period in the prior year.

Headline financials

Total Revenue

$74.3M

Previous: $84.2M-11.7%
EPS (adj)

$1.16

Previous: $1.46-20.5%
Net Income

$39.2M

Previous: $44.4M-11.6%
Operating Income

$33.7M

Previous: $44.4M-24.2%
Gross Profit

$72.2M

Previous: $82.7M-12.8%
Cash & Equivalents

$32.5M

Previous: $46.9M-30.5%
Total Assets

$3.08B

Previous: $3.17B-2.8%
Stock-Based Comp

$992K

Previous: $470K+111.1%

Revenue & EPS history

NHI · Revenue · Quarterly

$74.3M

Q2 2021-11.7%vs Q2 2020
Beat estimate in 7 of 16 quarters(44%)
ActualEstimate

Revenue by segment

NHI · $68.4M total across 1 segment · Q2 2021

  • Rental income
    $68.4M

Forward guidance

The company anticipates some of its tenants may need additional rent deferrals to assist them with the impact of the pandemic on their operations. The timing and amount of any additional deferrals cannot yet be determined.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

+0.1%

Avg return

Earnings day

+0.6%

Avg return

5 days after

+1.3%

Avg return

30 days after

59%

40 / 68 earnings

Positive

+14.9%

Q3 2020

Best reaction

-7.9%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.4%-1.9%-9.4%
Q4 2025-4.2%-3.2%-6.3%
Q3 2025+1.8%+1.1%+4.1%
Q1 2025+0.5%+1.0%-6.2%
Q4 2024-0.2%+2.9%+4.8%
Q3 2024+1.1%+7.0%-0.4%
Q2 2024+3.0%+3.2%+13.8%
Q1 2024+1.4%+0.9%+2.8%
Q4 2023+6.6%+8.4%+16.5%
Q3 2023+0.5%-0.7%+7.8%
Q2 2023-7.5%-6.7%-9.4%
Q1 2023+7.6%+8.3%+8.0%
Q4 2022-7.9%-6.5%-17.5%
Q3 2022-1.4%+3.4%+2.1%
Q2 2022+2.6%+4.9%+4.5%
Q1 2022-3.4%+1.4%+12.8%
Q4 2021-3.2%-2.0%+6.4%
Q3 2021+1.4%+1.8%+1.4%
Q2 2021-6.2%-5.5%-9.7%
Q1 2021-3.1%-4.9%-5.6%
Q4 2020-0.6%+0.1%+7.5%
Q3 2020+14.9%+18.0%+20.7%
Q2 2020+0.1%-2.8%-1.0%
Q1 2020-4.2%-11.3%+19.2%
Q4 2019+1.4%+1.8%-57.5%
Q3 2019-2.0%-2.0%+1.0%
Q2 2019+2.1%+2.0%+3.9%
Q1 2019-1.2%+0.8%+3.4%
Q4 2018-6.9%-4.0%-5.7%
Q3 2018+1.6%+2.4%+8.0%
Q2 2018+1.0%+0.1%+3.1%
Q1 2018+1.9%+1.7%+6.7%
Q4 2017+0.0%+0.8%+7.5%
Q3 2017-2.9%-1.5%-0.6%
Q2 2017+1.0%+2.8%+6.7%
Q1 2017+2.5%+4.4%+5.1%
Q4 2016+0.7%+1.1%-3.9%
Q3 2016-0.3%-5.5%+1.1%
Q2 2016+0.6%+2.0%+3.4%
Q1 2016+1.9%
Q4 2015+3.8%
Q3 2015-0.1%
Q2 2015-1.9%
Q1 2015+1.5%
Q4 2014+0.4%
Q3 2014-0.7%
Q2 2014+2.6%
Q1 2014+1.5%
Q4 2013-1.0%
Q3 2013-0.7%
Q2 2013-0.0%
Q1 2013+3.3%
Q4 2012-1.1%
Q3 2012+1.3%
Q2 2012-2.7%
Q1 2012+1.2%
Q4 2011-2.4%
Q3 2011+0.8%
Q2 2011-5.4%
Q1 2010-2.5%
Q1 2011+0.1%
Q4 2008+0.2%
Q4 2010+0.2%
Q3 2010+1.6%
Q3 2009+1.6%
Q2 2010+0.9%
Q2 2009+0.9%
Q4 2009+0.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro